James Vincent Lambert - 10 Jun 2021 Form 3 Insider Report for PRECIGEN, INC. (PGEN)

Role
Ex. Dir. Fin., PGEN Ther. Inc.
Signature
/s/ James V. Lambert, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
3
Filing time
21 Jun 2021, 20:47:12 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PGEN Common Stock 12,356 10 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PGEN Option to Purchase Common Stock (Right to Buy) 10 Jun 2021 Common Stock 10,000 $22.56 Direct F1
holding PGEN Option to Purchase Common Stock (Right to Buy) 10 Jun 2021 Common Stock 10,000 $8.17 Direct F2
holding PGEN Restricted Stock Units 10 Jun 2021 Common Stock 2,170 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options are fully vested.
F2 The stock options vest in equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025.
F3 The restricted stock units ("RSUs") vest in full on January 2, 2022.
F4 Each RSU represents a contingent right to receive one share of Precigen Common Stock.